Afoxolaner 2.27% Chewable Tablet (11.3 Mg)
116 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
116
Total Reports
1
Deaths Reported
90.0%
Death Rate
Active Ingredients
Afoxolaner 2.27% Chewable Tablet (11.3 Mg)
Administration Routes
OralUnknownOther
Species Affected
Dog 116
Most Affected Breeds
Terrier - Yorkshire 27
Shih Tzu 12
Dog (unknown) 11
Chihuahua 8
Crossbred Canine/dog 6
Maltese 6
Poodle - Toy 6
Spitz - German Pomeranian 5
Poodle - Miniature 4
Terrier - Jack Russell 3
Most Reported Reactions
Vomiting 39
Skin disorders NOS 29
Lack of efficacy (ectoparasite) - flea 15
Lack of efficacy (ectoparasite) - tick NOS 15
Diarrhoea 11
Itching 9
Pruritus 9
Lethargy (see also Central nervous system depression in 'Neurological') 9
Seizure NOS 5
Lack of efficacy - NOS 5
Reddening of the skin 5
Uncoded sign 4
Outcome Breakdown
Recovered/Normal
57 (49.1%)
Outcome Unknown
52 (44.8%)
Ongoing
6 (5.2%)
Died
1 (0.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.